• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物和藻类中的凝集素可作为抗 HIV、流感和冠状病毒的抗病毒药物。

Lectins from plants and algae act as anti-viral against HIV, influenza and coronaviruses.

机构信息

Centre for Bio-separation Technology (CBST), Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, 632014, India.

出版信息

Mol Biol Rep. 2022 Dec;49(12):12239-12246. doi: 10.1007/s11033-022-07854-8. Epub 2022 Sep 22.

DOI:10.1007/s11033-022-07854-8
PMID:36138301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9510388/
Abstract

BACKGROUND

Carbohydrate-lectin interactions are extremely specific as the lectin is capable of recognising monomeric and oligomeric sugars in a reversible manner. It has been known for a long time that lectins have antibacterial, antifungal, and insecticidal activities. Recently, it has been reported that many lectins can prevent the virus growth by interacting with the viral envelop surface glycoprotein. Spike protein, which is found on the surface of some enveloped viruses, is heavily mannosylated and will have strong affinity for mannose specific lectins. According to the findings, lectins have a high binding affinity for the glycans of the SARS-CoV-2 spike glycoprotein, which contains N-glycosylation sites. As a result, various lectins are being researched and developed as anti-viral agents.

RESULTS

According to our in silico studies, the amino acid residues Asn487, Tyr489, Gln493, Lys417, and Tyr505 of the receptor binding domain (RBD) of SARS-CoV-2 formed an interaction with the model lectin Lablab purpureus lectin. Similar interaction for SARS-CoV-2 spike protein was observed with Griffithsin lectin (algal source) as well. These observations demonstrate that lectins could be one of the potential molecules for neutralising coronavirus infection.

CONCLUSION

This review focuses on anti-viral lectins isolated and characterized from plants and algae (last 5 years) and showed anti-viral properties against HIV, Influenza, and coronaviruses.

摘要

背景

糖-凝集素相互作用非常特异,因为凝集素能够以可逆的方式识别单体和寡糖。长期以来,人们一直知道凝集素有抗菌、抗真菌和杀虫活性。最近,据报道,许多凝集素可以通过与病毒包膜表面糖蛋白相互作用来阻止病毒生长。刺突蛋白存在于一些包膜病毒的表面,高度甘露糖化,与甘露糖特异性凝集素有很强的亲和力。根据这些发现,凝集素与 SARS-CoV-2 刺突糖蛋白的聚糖具有很高的结合亲和力,SARS-CoV-2 刺突糖蛋白含有 N-糖基化位点。因此,各种凝集素作为抗病毒剂正在被研究和开发。

结果

根据我们的计算机研究,SARS-CoV-2 受体结合域(RBD)的氨基酸残基 Asn487、Tyr489、Gln493、Lys417 和 Tyr505 与模式凝集素 Lablab purpureus lectin 相互作用。我们还观察到 SARS-CoV-2 刺突蛋白与 Griffithsin 凝集素(藻类来源)也有类似的相互作用。这些观察表明,凝集素可能是中和冠状病毒感染的潜在分子之一。

结论

本综述重点介绍了过去 5 年来从植物和藻类中分离和鉴定的具有抗病毒活性的凝集素,并显示出对 HIV、流感病毒和冠状病毒的抗病毒特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/3a9683361b91/11033_2022_7854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/3aa76832e7dc/11033_2022_7854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/d85ea00c8227/11033_2022_7854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/3a9683361b91/11033_2022_7854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/3aa76832e7dc/11033_2022_7854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/d85ea00c8227/11033_2022_7854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a99/9510388/3a9683361b91/11033_2022_7854_Fig3_HTML.jpg

相似文献

1
Lectins from plants and algae act as anti-viral against HIV, influenza and coronaviruses.植物和藻类中的凝集素可作为抗 HIV、流感和冠状病毒的抗病毒药物。
Mol Biol Rep. 2022 Dec;49(12):12239-12246. doi: 10.1007/s11033-022-07854-8. Epub 2022 Sep 22.
2
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.植物、真菌、藻类和蓝藻中的人特异性凝集素,作为 SARS-CoV、MERS-CoV 和 SARS-CoV-2(COVID-19)冠状病毒的潜在阻滞剂:生物医学视角。
Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619.
3
structural inhibition of ACE-2 binding site of SARS-CoV-2 and SARS-CoV-2 omicron spike protein by lectin antiviral dyad system to treat COVID-19.通过凝集素抗病毒二联体系统抑制 SARS-CoV-2 和 SARS-CoV-2 奥密克戎刺突蛋白的 ACE-2 结合位点治疗 COVID-19。
Drug Dev Ind Pharm. 2022 Oct;48(10):539-551. doi: 10.1080/03639045.2022.2137196. Epub 2022 Oct 27.
4
Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.人特异性、GalNAc/T/Tn 特异性和 Neu5Ac 特异性海藻糖凝集素作为 SARS-CoV-2(COVID-19)冠状病毒的聚糖探针。
Mar Drugs. 2020 Oct 29;18(11):543. doi: 10.3390/md18110543.
5
Engineering recombinantly expressed lectin-based antiviral agents.工程重组表达基于凝集素的抗病毒剂。
Front Cell Infect Microbiol. 2022 Sep 23;12:990875. doi: 10.3389/fcimb.2022.990875. eCollection 2022.
6
Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.植物凝集素作为有前景的抗病毒生物分子在寻找 COVID-19 根除策略中的应用。
Biomed Pharmacother. 2022 Feb;146:112507. doi: 10.1016/j.biopha.2021.112507. Epub 2021 Dec 7.
7
Sensing the interactions between carbohydrate-binding agents and -linked glycans of SARS-CoV-2 spike glycoprotein using molecular docking and simulation studies.使用分子对接和模拟研究来感知碳水化合物结合剂与 SARS-CoV-2 刺突糖蛋白的 - 连接聚糖之间的相互作用。
J Biomol Struct Dyn. 2022 Jun;40(9):3880-3898. doi: 10.1080/07391102.2020.1851303. Epub 2020 Dec 9.
8
Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.通过凝集素与 Spike 蛋白上的两个聚糖簇结合,实现对 SARS-CoV-2 的不可逆失活。
Biochemistry. 2023 Jul 18;62(14):2115-2127. doi: 10.1021/acs.biochem.3c00109. Epub 2023 Jun 21.
9
Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.Cyanovirin-N 与 SARS-CoV-2 刺突寡糖结合,结合部位不在受体结合域之外,能阻止 SARS-CoV-2 感染。
Proc Natl Acad Sci U S A. 2023 Mar 7;120(10):e2214561120. doi: 10.1073/pnas.2214561120. Epub 2023 Feb 28.
10
A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.食用菜豆中的一种碳水化合物结合蛋白能有效阻止流感病毒和 SARS-CoV-2 的感染。
Cell Rep. 2020 Aug 11;32(6):108016. doi: 10.1016/j.celrep.2020.108016. Epub 2020 Jul 24.

引用本文的文献

1
Chimerolectins: Classification, structural architecture, and functional perspectives.嵌合凝集素:分类、结构架构及功能展望
Protein Sci. 2025 Sep;34(9):e70261. doi: 10.1002/pro.70261.
2
First identification report for amino acid composition of red algae spp. obtained from Central Java, Indonesia.关于从印度尼西亚中爪哇获取的红藻属氨基酸组成的首次鉴定报告。
BioTechnologia (Pozn). 2024 Dec 19;105(4):325-335. doi: 10.5114/bta.2024.145254. eCollection 2024.
3
Identification of a Novel Antiviral Lectin against SARS-CoV-2 Omicron Variant from Shiitake-Mushroom-Derived Vesicle-like Nanoparticles.

本文引用的文献

1
In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2.对海洋真菌和蘑菇中的抗病毒化合物进行计算机辅助生物勘探,以快速开发抗SARS-CoV-2的营养保健品。
J Biomol Struct Dyn. 2023 Mar;41(5):1574-1585. doi: 10.1080/07391102.2021.2023048. Epub 2021 Dec 31.
2
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.植物、真菌、藻类和蓝藻中的人特异性凝集素,作为 SARS-CoV、MERS-CoV 和 SARS-CoV-2(COVID-19)冠状病毒的潜在阻滞剂:生物医学视角。
Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619.
3
从香菇衍生的囊泡样纳米颗粒中鉴定出一种针对 SARS-CoV-2 奥密克戎变异株的新型抗病毒凝集素。
Viruses. 2024 Sep 30;16(10):1546. doi: 10.3390/v16101546.
4
Lactic acid bacterial surface display of scytovirin inhibitors for anti-ebolavirus infection.用于抗埃博拉病毒感染的蓝藻素抑制剂的乳酸菌表面展示
Front Microbiol. 2023 Nov 23;14:1269869. doi: 10.3389/fmicb.2023.1269869. eCollection 2023.
5
The Antiviral Potential of Algal Lectins.藻类凝集素的抗病毒潜力。
Mar Drugs. 2023 Sep 28;21(10):515. doi: 10.3390/md21100515.
6
Bioactivity of Fucoidan-Rich Extracts from against Rotavirus and Foodborne Pathogens.褐藻糖胶丰富提取物对轮状病毒和食源性病原体的生物活性。
Mar Drugs. 2023 Aug 30;21(9):478. doi: 10.3390/md21090478.
7
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19.植物作为生产治疗性蛋白质和抗病毒化合物以对抗新冠病毒的生物工厂。
Life (Basel). 2023 Feb 23;13(3):617. doi: 10.3390/life13030617.
COVID-19: from an acute to chronic disease? Potential long-term health consequences.
新型冠状病毒肺炎:从急性疾病转为慢性疾病?潜在的长期健康影响。
Crit Rev Clin Lab Sci. 2021 Aug;58(5):297-310. doi: 10.1080/10408363.2020.1860895. Epub 2020 Dec 21.
4
Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives.过去四十年的病毒性大流行:发病机制、健康影响和展望。
Int J Environ Res Public Health. 2020 Dec 15;17(24):9411. doi: 10.3390/ijerph17249411.
5
[COVID-19 and vaccination: a global disruption].[新冠疫情与疫苗接种:一场全球混乱]
Med Sci (Paris). 2020 Nov;36(11):1034-1037. doi: 10.1051/medsci/2020203. Epub 2020 Nov 5.
6
Exploring lectin-glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses.探索凝集素-聚糖相互作用以对抗 COVID-19:从其他包膜病毒中获得的经验。
Glycobiology. 2021 May 3;31(4):358-371. doi: 10.1093/glycob/cwaa099.
7
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.新型冠状病毒病 2019(COVID-19):作用机制、检测和最近的治疗策略。
Virology. 2020 Dec;551:1-9. doi: 10.1016/j.virol.2020.08.011. Epub 2020 Sep 24.
8
The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.人致病性冠状病毒的出现:作为针对 SARS-CoV-2 的抗病毒药物的凝集素。
Curr Pharm Des. 2020;26(41):5286-5292. doi: 10.2174/1381612826666200821120409.
9
A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.食用菜豆中的一种碳水化合物结合蛋白能有效阻止流感病毒和 SARS-CoV-2 的感染。
Cell Rep. 2020 Aug 11;32(6):108016. doi: 10.1016/j.celrep.2020.108016. Epub 2020 Jul 24.
10
Sialyl-Lewis Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy.唾液酸化路易斯糖抗原在治疗期间具有持续 HIV 转录的细胞中富集。
Cell Rep. 2020 Aug 4;32(5):107991. doi: 10.1016/j.celrep.2020.107991.